Clinical Edge Journal Scan

Atopic dermatitis increases the risk for type 2 diabetes mellitus in adults


 

Key clinical point: Adults with newly diagnosed atopic dermatitis (AD) have a 44% increased risk of subsequently developing type 2 diabetes (T2D).

Major finding: The risk for new-onset T2D was significantly higher in adults with newly diagnosed AD vs control individuals without AD (adjusted hazard ratio 1.44; P < .001), with the risk being significantly greater in both men and women with AD (both P < .001).

Study details: Findings are from a retrospective cohort study including 36,692 adult patients with AD and 36,692 matched control individuals who had never been diagnosed with AD.

Disclosures: This study was supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology and others. The authors declared no conflicts of interest.

Source: Won Lee S et al. Risk of type 2 diabetes mellitus in adult patients with atopic dermatitis. Diabetes Res Clin Pract. 2023;110883 (Aug 16). doi: 10.1016/j.diabres.2023.110883

Recommended Reading

EMA validates marketing authorization application for delgocitinib cream
MDedge Dermatology
Dupilumab gains off-label uses as clinicians turn to drug for more indications
MDedge Dermatology
Consider housing insecurity, other issues when managing challenging skin diseases in children, expert says
MDedge Dermatology
Commentary: Newer Drugs for AD Plus Dupilumab and Other Issues, September 2023
MDedge Dermatology
Atopic dermatitis may be a risk factor for GBS colonization in pregnancy
MDedge Dermatology
Almonds and almond oil
MDedge Dermatology
Company submits supplemental NDA for topical atopic dermatitis treatment
MDedge Dermatology
Dupilumab improves sleep outcomes in atopic dermatitis
MDedge Dermatology
Atopic dermatitis tied to a higher risk for inflammatory bowel disease in children and adults
MDedge Dermatology
Tralokinumab is safe and effective in older patients with atopic dermatitis
MDedge Dermatology